×
About 83 results

ALLMedicine™ Adrenocorticotropin Center

Research & Reviews  33 results

Determining the effectiveness of using dermal swabs to evaluate the stress physiology o...
https://doi.org/10.1016/j.ygcen.2021.113903
General and Comparative Endocrinology; Chancellor S, Abbo L et. al.

Sep 17th, 2021 - To better comprehend the physiology of cephalopods, we used a minimal invasive technique of skin mucus swabs to measure immunoreactive corticosteroids in three cephalopod species commonly kept in captivity and promoted as new model organisms: Eupr...

Primary Adrenal Insufficiency Due to Bilateral Adrenal Infarction in COVID-19.
https://doi.org/10.1210/clinem/dgab557
The Journal of Clinical Endocrinology and Metabolism; Machado IFR, Menezes IQ et. al.

Sep 1st, 2021 - Coronavirus disease 2019 (COVID-19) is a proinflammatory and prothrombotic condition, but its impact on adrenal function has not been adequately evaluated. A 46-year-old woman presented with abdominal pain, hypotension, and skin hyperpigmentation ...

Contrast-enhanced 3D-T2-weighted SPACE sequence for MRI detection and localization of a...
https://doi.org/10.1111/cen.14574
Clinical Endocrinology; Wu Y, Cai Y et. al.

Jul 30th, 2021 - Cushing disease is a potentially fatal endocrine disorder caused by adrenocorticotropin (ACTH)-secreting microadenomas in the pituitary gland. Accurate detection and localization of the adenomas is the key to clinical treatment. This study analyse...

Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372657
The Journal of Clinical Endocrinology and Metabolism; Araki T, Tone Y et. al.

Jun 2nd, 2021 - Mechanisms underlying pituitary corticotroph adenoma adrenocorticotropin (ACTH) production are poorly understood, yet circulating ACTH levels closely correlate with adenoma phenotype and clinical outcomes. We characterized the 5' ends of proopiome...

Comparison of a combination test (1 μg ACTH test plus glucagon test) versus 1 μg ACTH t...
https://doi.org/10.20945/2359-3997000000266
Archives of Endocrinology and Metabolism; Unluhizarci K, Kokoglu EO et. al.

May 26th, 2021 - To investigate whether a combination of the low-dose (1 μg) adrenocorticotropin (ACTH) stimulation test and glucagon stimulation test (GST) could overcome the problem of equivocal results with the GST or ACTH test alone in patients with pituitary ...

see more →